Soochow: MIXUE GROUP (02097) is rated as "buy" with a target price of HK$509.
Dongwu Securities pointed out that the core strengths of MEXI Group are brand power and dominance in the affordable ready-to-drink beverage market, and there is also great potential for expansion overseas.
Soochow released a research report stating that it has initiated coverage of MIXUE GROUP (02097) with a "Buy" rating and a target price of HK$509. The bank forecasted that the Group's net profit attributable to shareholders for the fiscal years 2024 to 2026 would be RMB 4.38 billion, RMB 5.12 billion, and RMB 5.94 billion respectively, corresponding to a P/E ratio of 28, 24, and 21 times.
Soochow pointed out that MIXUE GROUP, as a leading player in the affordable instant beverage market, has built a core barrier with its self-built end-to-end supply chain system and IP-based brand marketing to shape brand awareness. In addition, the company deepens its presence in the lower-tier markets through a franchise model, expands its brand internationally, and continues to strengthen its position in the industry.
Soochow also noted that the core strengths of MIXUE GROUP lie in its brand power and dominance in the affordable instant beverage market, and its potential in international expansion. Analogous to some strong brands that recently went public in the past year, such as MAO GEPING (01318) and LAOPU GOLD (06181), MIXUE GROUP is expected to enjoy a valuation premium, with a target P/E ratio of 30 times for the fiscal year 2026.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025